8RBV

SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant (VLNDILARL) presented by HLA-A*02:01

Summary for 8RBV

Entry DOI	10.2210/pdb8rbv/pdb
Descriptor	HLA class I antigen, Beta-2-microglobulin, SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant, ... (8 entities in total)
Functional Keywords	human leukocyte antigen, major histocompatibility complex, hla-a2, hla-a*02:01, sars-cov-2, spike, immune system
Biological source	Homo sapiens (human) More
Total number of polymer chains	3
Total formula weight	54454.56
Authors	Ahn, Y.M.,Maddumage, J.C.,Szeto, C.,Gras, S. (deposition date: 2023-12-05, release date: 2024-05-15, Last modification date: 2024-05-22)
Primary citation	Ahn, Y.M.,Maddumage, J.C.,Grant, E.J.,Chatzileontiadou, D.S.M.,Perera, W.W.J.G.,Baker, B.M.,Szeto, C.,Gras, S. The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific. Curr Res Struct Biol, 7:100148-100148, 2024 Cited by PubMed: 38742159 DOI: 10.1016/j.crstbi.2024.100148 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.8 Å)

Structure validation